RUNX3 Has an Oncogenic Role in Head and Neck Cancer
Open Access
- 12 June 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (6), e5892
- https://doi.org/10.1371/journal.pone.0005892
Abstract
Runt-related transcription factor 3 (RUNX3) is a tumor suppressor of cancer and appears to be an important component of the transforming growth factor-beta (TGF-ß)-induced tumor suppression pathway. Surprisingly, we found that RUNX3 expression level in head and neck squamous cell carcinoma (HNSCC) tissues, which is one of the most common types of human cancer, was higher than that in normal tissues by a previously published microarray dataset in our preliminary study. Therefore, here we examined the oncogenic role of RUNX3 in HNSCC. Frequent RUNX3 expression and its correlation with malignant behavior were observed in HNSCC. Ectopic RUNX3 overexpression promoted cell growth and inhibited serum starvation-induced apoptosis and chemotherapeutic drug induced apoptosis in HNSCC cells. These findings were confirmed by RUNX3 knockdown. Moreover, RUNX3 overexpression enhanced tumorsphere formation. RUNX3 expression level was well correlated with the methylation status in HNSCC cells. Moreover, RUNX3 expression was low due to the methylation of its promoter in normal oral epithelial cells. Our findings suggest that i) RUNX3 has an oncogenic role in HNSCC, ii) RUNX3 expression observed in HNSCC may be caused in part by demethylation during cancer development, and iii) RUNX3 expression can be a useful marker for predicting malignant behavior and the effect of chemotherapeutic drugs in HNSCC.This publication has 38 references indexed in Scilit:
- EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growthCancer Science, 2006
- Runx3 expression during mouse tongue and palate developmentThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2006
- Spreading of methylation within RUNX3 CpG island in gastric cancerCancer Science, 2005
- RUNX3 Inactivation by Point Mutations and Aberrant DNA Methylation in Bladder TumorsCancer Research, 2005
- Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 miceOncogene, 2005
- Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinomaLiver International, 2005
- Role of Cks1 Overexpression in Oral Squamous Cell Carcinomas: Cooperation with Skp2 in Promoting p27 DegradationThe American Journal of Pathology, 2004
- Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell linesOncogene, 2004
- Frequent Loss of RUNX3 Expression by Promoter Hypermethylation in Gastric CarcinomaPathobiology, 2004
- Hypomethylation of ras oncogenes in primary human cancersBiochemical and Biophysical Research Communications, 1983